| 000 | 01434 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515111722.0 | ||
| 264 | 0 | _c20080806 | |
| 008 | 200808s 0 0 eng d | ||
| 022 | _a1476-5500 | ||
| 024 | 7 |
_a10.1038/cgt.2008.17 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRautsi, O | |
| 245 | 0 | 0 |
_aCharacterization of HIV-1 TAT peptide as an enhancer of HSV-TK/GCV cancer gene therapy. _h[electronic resource] |
| 260 |
_bCancer gene therapy _cMay 2008 |
||
| 300 |
_a303-14 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCHO Cells |
| 650 | 0 | 4 |
_aCell Death _xdrug effects |
| 650 | 0 | 4 | _aCricetinae |
| 650 | 0 | 4 | _aCricetulus |
| 650 | 0 | 4 |
_aGanciclovir _xtherapeutic use |
| 650 | 0 | 4 |
_aGenetic Therapy _xmethods |
| 650 | 0 | 4 |
_aHerpesvirus 1, Human _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xgenetics |
| 650 | 0 | 4 |
_aPeptide Fragments _xtherapeutic use |
| 650 | 0 | 4 |
_aThymidine Kinase _xgenetics |
| 650 | 0 | 4 |
_atat Gene Products, Human Immunodeficiency Virus _xchemistry |
| 700 | 1 | _aLehmusvaara, S | |
| 700 | 1 | _aKetola, A | |
| 700 | 1 | _aMäättä, A-M | |
| 700 | 1 | _aWahlfors, J | |
| 700 | 1 | _aPellinen, R | |
| 773 | 0 |
_tCancer gene therapy _gvol. 15 _gno. 5 _gp. 303-14 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/cgt.2008.17 _zAvailable from publisher's website |
| 999 |
_c17812474 _d17812474 |
||